Remedium Spółka z Ograniczoną Odpowiedzialnością (KRS 0000281635, NIP 9271892535) is a Polish company, headquartered in Łódź, Łódzkie voivodeship. REMEDIUM operates in: Dispensing chemist in specialised stores (PKD 47.73.Z). Industry: Retail trade. The company has been listed in the National Court Register since May 25, 2007. REMEDIUM's most recently reported net revenue was 16.6 M PLN for 2024.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Remedium
Identity
- Name
- Remedium Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- May 25, 2007
- Registry status as of
- May 27, 2026
- Latest entry
- May 27, 2026
- Founding act
- 09.05.2007R. NOTARIUSZ ANNA SŁUPIŃSKA-MITAS KANCELARIA NOTARIALNA W KATOWICACH, REPERTORIUM A NR 7061/2007
Articles of association history (5)
- May 9, 2007: 09.05.2007R. NOTARIUSZ ANNA SŁUPIŃSKA-MITAS KANCELARIA NOTARIALNA W KATOWICACH, REPERTORIUM A NR 7061/2007
- February 7, 2008: 07.02.2008R. - NOTARIUSZ MAŁGORZATA JANIK-RYMARCZYK, KANCELARIA NOTARIALNA W KATOWICACH; REP.A NR 1255/2008 - ZMIANA §3.
- April 10, 2009: AKTEM NOTARIALNYM Z DNIA 10.04.2009 R., REPERTORIUM A NR 4081/2009, SPORZĄDZONYM PRZEZ NOTARIUSZA MAŁGORZATĘ Z. KRÓL W KANCELARII NOTARIALNEJ W ŁODZI, PRZY UL. ŻWIRKI NR 19, ZMIENIONO PAR.3 STATUTU SPÓŁKI.
- AKTEM NOTARIALNY Z DNIA 13 LISTOPADA 2009 R., REPERTORIUM A NR 11784/2009, SPORZĄDZONYM PRZEZ NOTARIUSZA MAŁGORZATĘ Z.KRÓL, PROWADZĄCĄ KANCELARIĘ NOTARIALNĄ W ŁODZI PRZY UL. ŻWIRKI NR 19, ZMIENIONO PAR.6 I PAR.17 UST.1, 2 I 3 UMOWY SPÓŁKI, A W PAR.15 DODANO UST.5
- November 7, 2017: 07.11.2017R., NOTARIUSZ MAŁGORZATA Z. KRÓL, KANCELARIA NOTARIALNA W ŁODZI, REPERTORIUM A NR 6576/2017 - ZMIANA § 7 UMOWY SPÓŁKI.
Activities
Main activity
47.73.ZDispensing chemist in specialised stores
Other activities
Address and contact
- Address
- KINGA C. GILLETTE, 11, 94-406, ŁÓDŹ, POLSKA
- Voivodeship
- ŁÓDZKIE
- District
- M. ŁÓDŹ
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-59308-77394-WCDTC-24
Risk and payment profile - Remedium
Credibility rating
28.8 / 100
Poor credibility
Insolvency risk
Moderate
Significant formal threat
Closure risk
14
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
3
3/19 yrs
Board changes
7
7/19 yrs
PKD changes
2
2/19 yrs
Name changes
0
0/19 yrs
Data from 19 years of registry activity.
Credibility history
Payment reliability score from 2018–2024
Current: E (29/100)
Trend: deteriorating (-11.0 pts/year)
Bardzo słaba wiarygodność płatnicza – współpraca handlowa wiąże się z wysokim ryzykiem braku zapłaty.
Trade credit limit history
Standard limit from 2018–2024
Current: 230.6 K PLN
Safe: 39.2 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Remedium
Founded
May 25, 2007
19 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
ŁÓDŹ
ŁÓDZKIE
Primary PKD
47.73.Z
Dispensing chemist in specialised stores
Share capital
52.0 K PLN
104 shares total
Shareholders
2
shareholders
Board
3 people
Filed years
7 years
2018–2024 · profitable: 4/7
Registry entries
43
latest: May 27, 2026
Risk signals
Revenue
16.6 M PLN
2024
Net profit
-17.4 K PLN
2024
Assets
4.0 M PLN
2024
Equity
412.2 K PLN
2024
EBITDA
-10.5 K PLN
2024
Valuation
2.2 M PLN
Low confidence
Low confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Remedium.
No ratings
Related articles
News
Ambra in 2026: PLN 48.1 m capex (+212%), PLN 1.10 dividend three years running, Cydr Lubelski plus Romanian Zarea as the premium engine
Warsaw-based Ambra S.A. (KRS 0000041726, ul. Puławska 336) closed H1 of fiscal 2025/2026 with PLN 556.8 m of revenue and PLN 49.0 m of net profit, while raising capex by 212% to PLN 48.1 m - mainly for the soft-drinks line in Wola Duża and the PLN 11.9 m acquisition of a Romanian company. Despite the aggressive investment cycle the board keeps a PLN 1.10 dividend per share for the third year running (~5.9% yield).
News
Answear in 2026: first full year without MCI, PLN 9.3 m net profit, but the supervisory board cuts the 2026 EBITDA target from PLN 100 m to PLN 90 m
Kraków-based Answear.com S.A. (KRS 0000816066) closed 2025 with revenue of PLN 1.7 bn (+13% YoY), EBITDA of PLN 56 m (+63%) and net profit of PLN 9.3 m - a return to the black after a PLN 10 m loss in 2024. Poland grew +31%, but CEE was under FX pressure (hryvnia -11% vs PLN), and a weak Q4 (EBITDA -71% YoY) forced the supervisory board to cut the 2026 EBITDA target from PLN 100 m to PLN 90 m and the target price from PLN 50 to PLN 45. It is the first full year after MCI's exit from the shareholder base (10 June 2025); the Bajołek brothers retain control (57.8%).
